News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 73–108
- Matches
- 3886
- Sources here
- 13
- Companies here
- 28
Active search
3886 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
CLEAR Secure, Inc. $YOU Shares Sold by Bank of America Corp DE
Bank of America Corp DE reduced its stake in CLEAR Secure, Inc. by 15.9% in Q1 2026, selling 137,309 shares and retaining 728,052 shares valued at $35.2 million. Other institutional investors also adjusted their positions, with overall institutional ownership at 73.8%. The company reported …
Assenagon Asset Management S.A. Buys New Position in AtriCure, Inc. $ATRC
Assenagon Asset Management S.A. has initiated a new position in AtriCure, Inc. (NASDAQ:ATRC), purchasing 62,334 shares valued at approximately $1.74 million. This move comes as AtriCure reported strong quarterly earnings, exceeding revenue estimates with $153.6 million and achieving an EPS of $0.18. Despite positive …
PIMCO reports 32.4% Venture Global (VG) Class A stake with 0.9% voting power
PIMCO has reported a beneficial ownership of 172,261,658 Class A Common Stock shares in Venture Global, representing 32.4% of the outstanding Class A shares. Despite this significant Class A ownership, PIMCO's total combined voting power in Venture Global is approximately 0.9% due to the …
How (HASI) Movements Inform Risk Allocation Models
This article analyzes Hannon Armstrong Sustainable Infrastructure Capital Inc. (NASDAQ: HASI) using AI models, indicating strong sentiment across all horizons and an exceptional 25.3:1 risk-reward setup. It outlines specific institutional trading strategies (Position Trading, Momentum Breakout, and Risk Hedging) with entry, target, and stop-loss …
Innventure (NASDAQ:INV) Downgraded to Sell Rating by Wall Street Zen
Innventure (NASDAQ:INV) has been downgraded to a "sell" rating by Wall Street Zen, adding to existing "sell" recommendations and a consensus target price of $5.00 from MarketBeat. This downgrade follows the company's significant Q2 loss of $0.32 per share, missed revenue estimates, and widening …
uniQure (NASDAQ:QURE) Upgraded by Wall Street Zen to "Hold" Rating
Wall Street Zen has upgraded uniQure (NASDAQ:QURE) from a "Sell" to a "Hold" rating, though the broader analyst consensus remains a "Moderate Buy" with an average target price of $65.00. Despite missing quarterly EPS estimates, the biotechnology company exceeded revenue expectations. Insider selling of …
Aureus Greenway (NASDAQ:PUSA) Upgraded by Wall Street Zen to Hold Rating
Wall Street Zen has upgraded Aureus Greenway (NASDAQ:PUSA) from a "sell" to a "hold" rating, though MarketBeat's overall average rating remains "Sell." The company's shares recently rose 4.9%, opening at $3.64, despite reporting breakeven EPS, negative net margin, and negative return on equity. Several …
FutureFuel (NYSE:FF) Upgraded to "Hold" at Wall Street Zen
Wall Street Zen upgraded FutureFuel (NYSE:FF) from a "sell" to a "hold" rating, while Weiss Ratings also slightly improved its "sell" rating. Despite this, the stock's overall analyst consensus remains "Sell." The company reported mixed financial results with positive EPS and revenue but continued …
Venture global SVP Sarah Blake sells $14 million in stock
Sarah Blake, SVP and Chief Accounting Officer at Venture Global, sold 1,000,000 shares of Class A Common Stock for $14,023,200 on August 14, 2026, following the exercise of stock options. This sale occurred as VG stock rose 50% in six months and despite the …
Ikarian Capital discloses 9.99% NextCure (NXTC) stake including large warrant position
Ikarian Capital, LLC and Neil Shahrestani have reported a beneficial ownership of 9.99% in NextCure, Inc. (NXTC), totaling 502,672 shares. This stake includes 449,369 shares that can be acquired within 60 days through warrants, which are subject to a 9.99% ownership cap. The calculation …
NextCure (NXTC) gains 15.8% beneficial owner in ADAR1 Capital and manager
ADAR1 Capital Management, LLC and its sole manager Daniel Schneeberger have reported a beneficial ownership of 15.8% of NextCure, Inc.'s common stock. This ownership, totaling 722,419 shares, is held by ADAR1-managed private funds and separately managed accounts, giving both ADAR1 and Schneeberger shared voting …
Figure Technology Solutions Reports Q2 2026 Financials in Form 10-Q Filing
Figure Technology Solutions, Inc. (NASDAQ:FIGR) filed its Q2 2026 Form 10-Q report with the SEC on August 14, 2026, detailing its financial results, share counts, and operational insights for the quarter ending June 30, 2026. The report highlighted the company's focus on home equity …
Blackstone Digital Infrastructure Trust Director Christopher Capossela Awarded 9,699 Restricted Shares
Christopher C. Capossela, a director at Blackstone Digital Infrastructure Trust Inc. (BXDC), was granted 9,699 restricted common stock shares on August 13, 2026, at no cost under the company's Stock Incentive Plan. These shares will vest at the issuer's 2027 annual meeting, provided Capossela …
Ralph Lauren Executive Halide Alagoz Sells 6,559 Class A Shares in August 2026
Halide Alagoz, Ralph Lauren's Chief Product & Merchandise Officer, sold 6,559 Class A Common Stock shares on August 10, 2026, at a weighted average price of $402.77 per share. This transaction, part of an estate planning and investment diversification strategy, leaves Alagoz with 18,851 …
Figure Technology Q2 2026 Earnings Call Transcript
Figure Technology reported a record Q2 2026 with $4.3 billion in consumer loan marketplace volume, up 132% year-over-year, driven by its Figure Connect platform which now accounts for 65% of volume and boasts 489 partners. The company achieved strong financial performance with nearly 100% …
AtriCure (ATRC) Is Up 10.1% After Unveiling 2030 Revenue Goal And Trial-Driven Expansion Plans
AtriCure (ATRC) saw a 10.1% stock increase after announcing a goal of US$1.00 billion in revenue by 2030, driven by its atrial fibrillation, left atrial appendage management, and postsurgical pain-management franchises, alongside new product launches. The company's expansion plans heavily rely on the successful …